Margarida Silva is a PhD student at Faculdade de Farmácia, Universidade de Lisboa; Faculdade de Farmácia, Universidade do Porto and NOVA School of Science and Technology and is enrolled in the PhD Programme in Medicines and Pharmaceutical Innovation (i3DU). She holds a Master’s Degree in Biochemistry (2016, Faculdade de Ciências, Universidade de Lisboa) and currently works in three groups: iMed.ULisboa (Lisbon, Portugal), LAQV/REQUIMTE (Porto, Portugal) and UCIBIO/REQUIMTE (Lisbon, Portugal). Her PhD in Pharmaceutical Technology is focused on developing drug delivery systems for treatment of hepatic ischemia and reperfusion injury.
Representative Publications
